CERT
Certara, Inc. NASDAQ Listed Dec 11, 2020$5.54
-8.13%
vs $6.03
Mkt Cap $861.8M
52w Low $4.45
11.6% of range
52w High $13.88
50d MA $5.63
200d MA $8.30
P/E (TTM)
-554.0x
EV/EBITDA
8.4x
P/B
0.8x
Debt/Equity
0.0x
ROE
-0.1%
P/FCF
9.4x
RSI (14)
45.00
ATR (14)
$0.37
Beta
1.62
50d MA
$5.63
200d MA
$8.30
Avg Volume
4.4M
Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, Australia, and China. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
100 Overlook Center · Princeton, NJ 08540 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | TNS | 0.11 | 0.09 | -18.2% | 5.13 | +2.1% | -0.8% | -5.9% | -3.8% | -2.8% | +1.8% | — |
| Feb 26, 2026 | TNS | 0.11 | 0.09 | -18.2% | 6.80 | -1.5% | +4.1% | -0.4% | +2.7% | +1.5% | -2.7% | — |
| Nov 6, 2025 | TNS | 0.11 | 0.14 | +27.3% | 11.27 | -1.9% | -23.1% | -0.6% | -0.5% | -3.5% | +1.6% | — |
| Aug 6, 2025 | TNS | 0.10 | 0.07 | -30.0% | 9.53 | +7.0% | +18.2% | -2.8% | -4.3% | +2.7% | +3.9% | — |
| May 5, 2025 | TNS | 0.13 | 0.14 | +7.7% | 12.78 | +2.6% | -11.0% | +0.8% | +3.6% | +0.9% | +1.3% | — |
| Feb 26, 2025 | TNS | 0.13 | 0.15 | +15.4% | 12.33 | +6.1% | +0.6% | -3.4% | -0.3% | -0.8% | +0.5% | — |
| Nov 6, 2024 | TNS | 0.11 | 0.13 | +18.2% | 10.91 | -1.2% | +0.7% | +0.4% | -1.3% | -2.7% | +1.0% | — |
| Aug 6, 2024 | TNS | 0.11 | 0.07 | -36.4% | 15.08 | -10.5% | -13.6% | +0.3% | -4.3% | -4.0% | +3.7% | — |
| May 7, 2024 | TNS | 0.10 | 0.10 | +0.0% | 17.66 | -4.6% | -7.4% | +4.3% | -0.4% | -2.1% | -1.4% | — |
| Feb 29, 2024 | TNS | 0.11 | 0.09 | -18.2% | 16.88 | +5.2% | +8.4% | +3.2% | -1.4% | +2.4% | +2.1% | — |
| Nov 8, 2023 | TNS | 0.11 | 0.11 | +0.0% | 12.48 | +5.6% | +1.4% | +6.7% | -3.6% | +11.3% | +1.7% | — |
| Aug 9, 2023 | TNS | 0.13 | 0.12 | -7.7% | 17.92 | -13.5% | -7.6% | +0.7% | +3.1% | -1.7% | -1.8% | — |
| May 8, 2023 | AMC | 0.12 | 0.12 | +0.0% | 23.42 | -8.9% | -10.7% | +0.2% | +0.2% | -3.2% | +0.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $5.55 | $5.53 | -0.4% | +4.3% | +0.5% | +5.7% | +0.2% | +1.0% |
| Mar 6 | Barclays | Downgrade | Overweight → Equal Weight | — | $7.15 | $6.92 | -3.2% | -1.3% | -0.3% | -1.6% | -3.9% | -1.5% |
| Feb 27 | Barclays | Maintains | Overweight → Overweight | — | $6.80 | $6.70 | -1.5% | +4.1% | -0.4% | +2.7% | +1.5% | -2.7% |
| Jan 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $9.49 | $9.50 | +0.1% | +1.9% | -3.5% | +0.6% | -2.6% | +1.9% |
| Jan 6 | Leerink Partners | Upgrade | Market Perform → Outperform | — | $9.04 | $9.43 | +4.3% | +5.9% | -0.8% | +1.9% | -3.5% | +0.6% |
| Dec 18 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $8.86 | $8.87 | +0.1% | +0.2% | +2.1% | +0.4% | -1.5% | -0.7% |
| Dec 15 | Barclays | Maintains | Overweight → Overweight | — | $8.58 | $8.66 | +0.9% | +1.9% | -0.9% | +2.3% | +0.2% | +2.1% |
| Dec 12 | Stephens & Co. | Maintains | Overweight → Overweight | — | $8.81 | $8.79 | -0.2% | -2.6% | +1.9% | -0.9% | +2.3% | +0.2% |
| Nov 7 | Barclays | Maintains | Overweight → Overweight | — | $11.27 | $11.06 | -1.9% | -23.1% | -0.6% | -0.5% | -3.5% | +1.6% |
| Oct 8 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $12.93 | $13.23 | +2.3% | +0.5% | -0.5% | -8.3% | +3.3% | -2.9% |
| Oct 2 | Barclays | Maintains | Overweight → Overweight | — | $13.37 | $13.48 | +0.8% | +1.7% | -3.9% | +2.9% | -3.9% | +0.5% |
| Aug 7 | UBS | Maintains | Buy → Buy | — | $9.53 | $10.20 | +7.0% | +18.2% | -2.8% | -4.3% | +2.7% | +3.9% |
| Jul 14 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $11.09 | $11.03 | -0.5% | +0.5% | -6.6% | +0.0% | +1.2% | -4.2% |
| May 8 | Barclays | Upgrade | Equal Weight → Overweight | — | $11.46 | $12.17 | +6.2% | +3.6% | +0.9% | +1.3% | +0.1% | -3.5% |
| May 6 | JMP Securities | Maintains | Market Perform → Market Perform | — | $12.78 | $13.11 | +2.6% | -11.0% | +0.8% | +3.6% | +0.9% | +1.3% |
| Apr 16 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $13.88 | $14.01 | +0.9% | -2.5% | +4.6% | +2.3% | -0.1% | -1.4% |
| Apr 11 | Baird | Maintains | Neutral → Neutral | — | $10.51 | $11.84 | +12.7% | +22.8% | +11.5% | -3.6% | -2.5% | +4.6% |
| Apr 10 | Barclays | Maintains | Equal Weight → Equal Weight | — | $9.73 | $9.49 | -2.5% | +8.0% | +22.8% | +11.5% | -3.6% | -2.5% |
| Feb 28 | Barclays | Maintains | Equal Weight → Equal Weight | — | $12.40 | $12.21 | -1.5% | -3.4% | -0.3% | -0.8% | +0.5% | -2.4% |
| Feb 27 | Stephens & Co. | Maintains | Overweight → Overweight | — | $12.33 | $13.08 | +6.1% | +0.6% | -3.4% | -0.3% | -0.8% | +0.5% |
| Nov 7 | Barclays | Maintains | Equal Weight → Equal Weight | — | $10.91 | $10.78 | -1.2% | +0.7% | +0.4% | -1.3% | -2.7% | +1.0% |
| Nov 5 | Baird | Maintains | Neutral → Neutral | — | $10.25 | $10.12 | -1.3% | +0.6% | +5.8% | +0.7% | +0.4% | -1.3% |
| Oct 15 | Barclays | Maintains | Equal Weight → Equal Weight | — | $11.24 | $11.19 | -0.4% | -0.3% | +0.1% | +3.1% | -1.4% | -1.8% |
| Sep 27 | UBS | Upgrade | Neutral → Buy | — | $10.70 | $11.59 | +8.3% | +9.8% | -0.3% | -3.1% | +0.2% | -3.3% |
| Aug 7 | Baird | Maintains | Neutral → Neutral | — | $15.08 | $13.49 | -10.5% | -13.6% | +0.3% | -4.3% | -4.0% | +3.7% |
| Aug 7 | UBS | Maintains | Neutral → Neutral | — | $15.08 | $13.49 | -10.5% | -13.6% | +0.3% | -4.3% | -4.0% | +3.7% |
| Jul 11 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $13.88 | $14.01 | +0.9% | +8.9% | +0.4% | +3.1% | +5.4% | +0.3% |
| Jun 28 | Barclays | Maintains | Equal Weight → Equal Weight | — | $13.65 | $13.74 | +0.7% | +1.5% | -1.5% | +0.1% | +1.3% | +2.7% |
| Apr 10 | KeyBanc Capital Markets | Upgrade | Sector Weight → Overweight | — | $18.51 | $18.20 | -1.7% | -0.3% | -0.1% | -4.2% | -1.3% | -2.1% |
| Mar 1 | UBS | Maintains | Neutral → Neutral | — | $16.88 | $17.75 | +5.2% | +8.4% | +3.2% | -1.4% | +2.4% | +2.1% |
| Mar 1 | Jefferies | Maintains | Hold → Hold | — | $16.88 | $17.75 | +5.2% | +8.4% | +3.2% | -1.4% | +2.4% | +2.1% |
| Jan 25 | Barclays | Maintains | Equal Weight → Equal Weight | — | $16.10 | $16.35 | +1.6% | +0.2% | +3.0% | -0.7% | -0.5% | -1.5% |
| Oct 11 | Stephens & Co. | Maintains | Overweight → Overweight | — | $14.36 | $14.38 | +0.1% | -0.6% | -2.9% | -0.9% | +1.6% | +0.9% |
| Aug 22 | Jefferies | Downgrade | Buy → Hold | — | $16.11 | $15.45 | -4.1% | -2.7% | +2.1% | -0.7% | +1.4% | -1.2% |
| Aug 15 | BofA Securities | Maintains | Buy → Buy | — | $17.19 | $17.09 | -0.6% | -1.7% | -1.8% | -2.2% | -1.2% | +0.4% |
| Aug 11 | Barclays | Maintains | Equal Weight → Equal Weight | — | $16.55 | $16.47 | -0.5% | +0.7% | +3.1% | -1.7% | -1.8% | -2.2% |
| Aug 10 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $17.92 | $15.50 | -13.5% | -7.6% | +0.7% | +3.1% | -1.7% | -1.8% |
| Aug 10 | William Blair | Downgrade | Outperform → Market Perform | — | $17.92 | $15.50 | -13.5% | -7.6% | +0.7% | +3.1% | -1.7% | -1.8% |
| Aug 10 | Credit Suisse | Maintains | Outperform → Outperform | — | $17.92 | $15.50 | -13.5% | -7.6% | +0.7% | +3.1% | -1.7% | -1.8% |
| Jul 27 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $19.26 | $19.36 | +0.5% | -3.2% | +2.7% | +1.6% | -1.9% | -2.6% |
| Apr 4 | Barclays | Downgrade | Overweight → Equal Weight | — | $23.57 | $23.74 | +0.7% | -2.0% | -0.9% | +0.5% | +0.3% | +0.2% |
| Apr 3 | Barclays | Downgrade | Overweight → Equal Weight | — | $24.11 | $23.12 | -4.1% | -2.2% | -2.0% | -0.9% | +0.5% | +0.3% |
| Mar 27 | Credit Suisse | Maintains | Outperform → Outperform | — | $23.65 | $24.02 | +1.6% | +0.8% | -0.2% | +0.3% | -0.3% | +1.3% |
| Mar 10 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $21.06 | $21.06 | +0.0% | -7.3% | +4.1% | +1.9% | -0.7% | +10.8% |
| Mar 2 | Credit Suisse | Maintains | Outperform → Outperform | — | $18.44 | $20.20 | +9.5% | +17.3% | +0.5% | -1.2% | -1.3% | +0.4% |
| Mar 2 | Barclays | Maintains | Overweight → Overweight | — | $18.44 | $20.20 | +9.5% | +17.3% | +0.5% | -1.2% | -1.3% | +0.4% |
| Jan 24 | Barclays | Maintains | Overweight → Overweight | — | $18.73 | $18.83 | +0.5% | -1.4% | +1.1% | +2.2% | +0.2% | -1.6% |
| Dec 14 | Baird | Downgrade | Outperform → Neutral | — | $17.40 | $17.05 | -2.0% | -6.4% | +0.7% | -1.4% | -0.1% | +0.9% |
| Nov 14 | Credit Suisse | Maintains | Outperform → Outperform | — | $14.65 | $14.54 | -0.8% | -0.1% | +6.4% | -3.7% | -5.7% | +6.4% |
| Oct 6 | Barclays | Maintains | Overweight → Overweight | — | $13.95 | $13.91 | -0.3% | -2.3% | -3.8% | -4.2% | -0.9% | -3.7% |
No insider trades available.
8-K
Certara, Inc. -- 8-K Filing
May 15
8-K · 2.02
!! High
Certara, Inc. -- 8-K 2.02: Earnings Results
Certara reported earnings results showing operational performance and financial condition changes, which are detailed in the attached press release that investors should review for specific revenue, profitability, and guidance updates.
May 11
8-K · 1.01
!! High
Certara, Inc. -- 8-K 1.01: Material Agreement
Certara acquired Veristat, LLC for $100 million, expanding its regulatory and clinical trial solutions capabilities through this strategic acquisition.
Apr 22
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
CERT's departure of a key executive signals potential leadership instability and strategy uncertainty, likely pressuring the stock until succession clarity emerges and investor confidence in continuity strengthens.
Mar 31
8-K
Certara, Inc. -- 8-K Filing
Certara reported modest 3% Q4 revenue growth to $103.6M with declining adjusted EBITDA, guiding 2026 revenue growth of 0-4% and adjusted EPS of $0.44-$0.48, signaling slowing momentum.
Feb 26
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 10,111,636 | $89M | Added | Dec 2025 |
| 2 | Deerfield Management Company, L.p. | 7,808,605 | $45M | — | Mar 2026 |
| 3 | Vanguard Portfolio Management Llc | 5,969,196 | $34M | New | Mar 2026 |
| 4 | Vanguard Capital Management Llc | 5,360,429 | $31M | New | Mar 2026 |
| 5 | Wasatch Advisors Lp | 5,272,166 | $30M | Reduced | Mar 2026 |
| 6 | Citadel Advisors Llc | 4,545,848 | $26M | Added | Mar 2026 |
| 7 | Ubs Group Ag | 3,420,632 | $19M | Added | Mar 2026 |
| 8 | Teacher Retirement System Of Texas | 2,960,963 | $17M | Reduced | Mar 2026 |
| 9 | Geneva Capital Management Llc | 2,743,484 | $16M | Reduced | Mar 2026 |
| 10 | Fort Washington Investment Advisors Inc /oh/ | 2,675,543 | $15M | Added | Mar 2026 |
| 11 | Brown Brothers Harriman & Co | 2,507,163 | $14M | Reduced | Mar 2026 |
| 12 | Select Equity Group, L.p. | 1,491,161 | $13M | Added | Dec 2025 |
| 13 | Bank Of America Corp /de/ | 2,042,946 | $12M | Added | Mar 2026 |
| 14 | Raymond James Financial Inc | 1,598,659 | $9M | Added | Mar 2026 |
| 15 | Dixon Mitchell Investment Counsel Inc. | 1,537,876 | $9M | Reduced | Mar 2026 |
| 16 | Gotham Asset Management | 1,414,779 | $8M | Added | Mar 2026 |
| 17 | Kopion Asset Management, Llc | 1,288,452 | $7M | Added | Mar 2026 |
| 18 | Millennium Management | 1,255,944 | $7M | Reduced | Mar 2026 |
| 19 | Point72 Asset Management | 1,118,967 | $6M | New | Mar 2026 |
| 20 | Royal Bank Of Canada | 1,009,089 | $6M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$861.8M
Enterprise Value
$707.6M
P/E (TTM)
-554.00x
Forward P/E
12.38x
PEG Ratio
10.22x
P/B
0.84x
P/S
2.12x
P/FCF
9.40x
EV/EBITDA
8.43x
Shares Out
160.4M
Financials (TTM)
Revenue
$418.8M
Net Income
-$1.6M
EBITDA
$83.9M
Free Cash Flow
$94.6M
Op Cash Flow
$96.3M
EPS Basic
$-0.01
EPS Diluted
$-0.01
EPS Forward
$0.45
Gross Margin
61.5%
Op Margin
5.0%
Net Margin
-0.4%
Balance Sheet
Total Assets
$1.56B
Total Liab.
$493.8M
Total Equity
$1.06B
Cash
$189.4M
LT Debt
$8.4M
Book Value/Sh
$6.63
Debt/Equity
0.01x
Current Ratio
2.05
Quick Ratio
2.05
Returns & Growth
ROE
-0.1%
ROA
-0.1%
ROIC
-0.3%
Rev Growth YoY
+8.8%
EPS Growth YoY
+86.7%
Price Returns
2W
+26.2%
1M
-5.1%
3M
-17.8%
6M
-36.5%
12M
-48.8%
Technicals
52W High
$13.88
52W Low
$4.45
50d MA
$5.63
200d MA
$8.30
RSI (14)
45.00
ATR (14)
$0.37
Beta
1.62
Avg Volume
4.4M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$10.00
High
$10.00
Low
$10.00
Median
$10.00
Data updated apr 25, 2026 12:48am
· Source: financialmodelingprep.com